Randomized dose-finding study of batefenterol via dry powder inhaler in patients with COPD

Courtney Crim1 GSK, Research and Development, Research Triangle Park, NC, USA, [email protected]Correspondence[email protected]

Michael L Watkins1 GSK, Research and Development, Research Triangle Park, NC, USA, [email protected]

Eric D Bateman2 Division of Pulmonology, Department of Medicine, University of Cape Town, Cape Town, South Africa

Gregory J Feldman3 S. Carolina Pharmaceutical Research, Spartanburg, SC, USA

Isabelle Schenkenberger4 Klinische Forschung Berlin GbR, Berlin, Germany

Edward M Kerwin5 Clinical Trials Division, Crisor LLC, Clinical Research Institute, Medford OR, USA

Catriona Crawford6 GSK, Global Medical, Stockley Park, Uxbridge, Middlesex, UK

Krishna Pudi7 Upstate Pharmaceutical Research, Greenville, SC, USA

Shuyen Ho8 PAREXEL International, Durham, NC, USA

Charlotte Baidoo9 GSK, Clinical Statistics, Stockley Park, Uxbridge, Middlesex, UK

Ramiro Castro-Santamaria10 GSK, Research and Development, Collegeville, PA, USA

Your download is now in progress and you may close this window